Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Aug 2007 |
100 Clinical Results associated with Emergent Sales & Marketing Australia Pty Ltd.
0 Patents (Medical) associated with Emergent Sales & Marketing Australia Pty Ltd.
100 Deals associated with Emergent Sales & Marketing Australia Pty Ltd.
100 Translational Medicine associated with Emergent Sales & Marketing Australia Pty Ltd.